← All institutions

Morgan Stanley

275 reports

Reports from this institution

Morgan Stanley

Morgan Stanley: China’s pharmaceutical exports grow, but pressure on API prices persists

Pharmaceutical exports rose 10.5% year on year in the first three quarters of 2026, but the trade deficit still widened to 21 billion US dollars. Morgan Stanley says excess capacity and low utilization continue to suppress active pharmaceutical ingredient (API) prices, prompting some manufacturers to move into finished formulations or CDMO services.

Morgan Stanley

Morgan Stanley: Sinoma Science & Technology’s third-quarter profit rises 46% year on year, broadly flat quarter on quarter

Higher glass fiber volumes and prices, together with higher lithium-ion battery separator volumes and prices in the third quarter, improved Sinoma Science & Technology’s profitability in the first three quarters. However, third-quarter revenue and net profit were both broadly flat quarter on quarter, and Morgan Stanley viewed the results as slightly below market consensus.

Morgan Stanley

Morgan Stanley: Sieyuan Electric: Revenue rose by thirty percent in the third quarter. Why did profit grow by only 4.5%?

Foreign exchange effects and a higher share of low-margin businesses weighed on earnings, while lower expense ratios provided a partial cushion. Overseas orders grew by more than 50%, supporting Morgan Stanley’s decision to maintain its Overweight rating, but the profit quality of converted orders remains subject to product mix, exchange rates and costs.

Morgan Stanley

Morgan Stanley: Vertex kidney disease pipeline: Full Pove data support approval; commercialization hinges on payer coverage and new patients

The full phase three Pove results are consistent with prior disclosures, and Morgan Stanley remains positive on its combination of efficacy, safety and convenient dosing. The near-term focus shifts to the 30 November regulatory decision and payer coverage after launch; another kidney disease drug, inaxaplin, is due to report kidney function data in early 2027.

Morgan Stanley

Morgan Stanley: Shennan Circuits’ third-quarter profit beats expectations: AI share rises to sixty percent, ABF moves toward quarterly profitability

Net profit in the third quarter of 2026 was 18% above the market consensus, driven mainly by a higher share of AI PCBs, rising capacity utilization and narrower ABF losses. Optical module PCB upgrades and packaging substrate capacity expansion offer room for further growth, but the ramp-up of 1.6T products and ABF profitability each have their own timing thresholds. Morgan Stanley maintains its Equal-weight rating.

Morgan Stanley

Morgan Stanley: China National Building Material narrows third-quarter loss: How much improvement can higher cement prices bring?

China National Building Material’s third-quarter net loss narrowed to 67 million yuan, but basic building materials remained weighed down by volumes and prices. Morgan Stanley expects cement price stabilization to drive a modest improvement in the fourth quarter, while new materials such as fiberglass continue to support growth. It maintains an Equal-weight rating.

Morgan Stanley

Morgan Stanley: Generalist AI: How far is commercialization after teaching robots with human-operated data?

Generalist uses handheld grippers to bypass the data collection bottleneck of robot teleoperation and has demonstrated the ability to perform new tasks after a few seconds of demonstration. Morgan Stanley values its data scale effects, but cross-robot transfer, task reliability, and the business model will determine whether technical progress translates into revenue.

Morgan Stanley

Morgan Stanley: Cambricon’s third-quarter price increases lift profits; inventory expansion supports expectations of higher volume in 2027

Third-quarter revenue met Morgan Stanley’s expectations, while the profit beat came mainly from price increases for the MLU580 and MLU590. Inventory rose 41% quarter on quarter, which the bank sees as preparation for a subsequent ramp-up, though slower revenue recognition for the MLU690 and rising memory procurement costs also pose constraints.

Morgan Stanley

Morgan Stanley: Nubank enters the US: Free remittances open the door, but profitability depends on converting users into deposit and credit customers

Nubank has launched savings, credit cards and cross-border transfers in the US. Morgan Stanley believes free remittances can attract Latino customers, but whether its low-cost advantage can cover US customer acquisition costs and losses on new credit will determine whether the business is worth expanding; the existing bullish thesis remains supported by its Latin American operations.

Morgan Stanley

Morgan Stanley: Boyd Gaming: Regional operations stabilize earnings as Las Vegas weakness leaves Morgan Stanley’s Overweight view unchanged

Boyd’s third-quarter revenue fell slightly short of expectations, but cost controls and the online and management businesses supported a modest earnings beat overall. Morgan Stanley believes stable fundamentals and continued buybacks support its low-valuation view, although Las Vegas traffic and core brick-and-mortar margins remain under pressure.

Morgan Stanley

Morgan Stanley: Pinggao Electric: UHV deliveries lift profits, while order backlog supports future growth

Pinggao Electric’s third-quarter net profit rose 30.5% year on year, as increased deliveries of ultra-high-voltage (UHV) GIS lifted its gross margin. Morgan Stanley is optimistic that full-year deliveries will exceed the target and that orders on hand will provide support, but growth in new orders is concentrated in high-voltage products, and future earnings are also subject to tendering schedules, competition and cost control.